Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
US8563714B2 · kind B2 · utility
3Cited by
0References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2010 |
| Grant date | Oct 22, 2013 |
| Priority date | — |
| Expiry date | Jun 13, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/94
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to bridged spiro[2.4]heptane derivatives of formula (I), wherein W, Y, Z, R1 and R2 are as defined in the description, their preparation and their use as pharmaceutically active compounds as ALX receptor and/or FPRL2 agonists for the treatment of inflammatory and obstructive airways diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.